Cargando…

Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study

BACKGROUND: Treating patients with latent tuberculosis infection (LTBI) to prevent development of active disease is an essential strategy for eliminating TB. There are concerns regarding the use of isoniazid due to the potential for hepatotoxicity. This study was conducted to determine the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mudzviti, Tinashe, Shamu, Tinei, Chimbetete, Cleophas, Munengerwa, Tilda, Bote, Sandra, Pascoe, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422975/ https://www.ncbi.nlm.nih.gov/pubmed/30758779 http://dx.doi.org/10.1007/s40801-019-0147-3

Ejemplares similares

Profile of elderly patients receiving antiretroviral therapy at Newlands Clinic in 2020: A cross-sectional study
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Outcomes of an HIV cohort after a decade of comprehensive care at Newlands Clinic in Harare, Zimbabwe: TENART cohort
por: Shamu, Tinei, et al.
Publicado: (2017)

Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study
por: Shamu, Tinei, et al.
Publicado: (2021)

Zimbabwe’s national third-line antiretroviral therapy program: Cohort description and treatment outcomes
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
por: Shawarira-Bote, Sandra, et al.
Publicado: (2019)

Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Sexually transmitted infections, the silent partner in HIV-infected women in Zimbabwe
por: Lowe, Sara, et al.
Publicado: (2019)

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
por: Kasimonje, Bahati, et al.
Publicado: (2021)

Comparison of predictors for early and late mortality in adults commencing HIV antiretroviral therapy in Zimbabwe: a retrospective cohort study
por: Byers, Bradley W., et al.
Publicado: (2022)

Cervical Cancer Screening Cascade for women living with HIV: A cohort study from Zimbabwe
por: Taghavi, Katayoun, et al.
Publicado: (2022)

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2018)

Cervical human papillomavirus prevalence, risk factors and outcomes in a cohort of HIV-infected women in Harare, Zimbabwe
por: Mandiriri, Ardele M., et al.
Publicado: (2020)

Cancer incidence among people living with HIV in Zimbabwe: A record linkage study
por: Shamu, Tinei, et al.
Publicado: (2021)

Comparison of CG, CKD-EPI[AS] and CKD-EPI[ASR] equations to estimate glomerular filtration rate and predict mortality in treatment naïve people living with HIV in Zimbabwe
por: Hunter-Dickson, Mitchell, et al.
Publicado: (2023)

A case report of untreatable HIV infection in Harare, Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2019)

Pellagra in isoniazid preventive and antiretroviral therapy
por: Kipsang, John Koech, et al.
Publicado: (2019)

The Impact of Herbal Drug Use on Adverse Drug Reaction Profiles of Patients on Antiretroviral Therapy in Zimbabwe
por: Mudzviti, Tinashe, et al.
Publicado: (2012)

Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study
por: Tsirizani-Galileya, Lufina, et al.
Publicado: (2022)

Patterns of detectable viraemia among children and adults with HIV infection taking antiretroviral therapy in Zimbabwe
por: Sovershaeva, Evgeniya, et al.
Publicado: (2019)

Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study
por: Kazibwe, Andrew, et al.
Publicado: (2022)

Metabolic syndrome among treatment‐naïve people living with and without HIV in Zambia and Zimbabwe: a cross‐sectional analysis
por: Chihota, Belinda V., et al.
Publicado: (2022)

Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes
por: Ballif, Marie, et al.
Publicado: (2018)

When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa
por: Schomaker, Michael, et al.
Publicado: (2013)

Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia
por: Yirdaw, Kesetebirhan Delele, et al.
Publicado: (2014)

Real‐world use and outcomes of dolutegravir‐containing antiretroviral therapy in HIV and tuberculosis co‐infection: a site survey and cohort study in sub‐Saharan Africa
por: Romo, Matthew L., et al.
Publicado: (2022)

Antiretroviral therapy and liver disorders in the OPERA(®) cohort
por: Wohlfeiler, Michael, et al.
Publicado: (2020)

Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study
por: Denholm, Justin T, et al.
Publicado: (2014)

Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
por: Ayele, Henok Tadesse, et al.
Publicado: (2015)

Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort
por: Salazar-Austin, Nicole, et al.
Publicado: (2019)

Evolution of resistance in paediatric patients with failure on antiretroviral therapy
por: Orrell, C, et al.
Publicado: (2012)

Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy
por: Taylor, Allan W., et al.
Publicado: (2013)

Factors associated with antiretroviral therapy adherence among adolescents living with HIV in the era of isoniazid preventive therapy as part of HIV care
por: Villiera, Jimmy Ba, et al.
Publicado: (2022)

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa
por: Reddi, Anand, et al.
Publicado: (2007)

Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use
por: Hahn, Judith A., et al.
Publicado: (2023)

Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda
por: Ferguson, Olivia, et al.
Publicado: (2020)

Hyperglycaemia induced by isoniazid preventive therapy
por: Ganguly, Roshni Jhan, et al.
Publicado: (2018)

Trend analysis of tuberculosis case notifications with scale-up of antiretroviral therapy and roll-out of isoniazid preventive therapy in Zimbabwe, 2000–2018
por: Takarinda, Kudakwashe C, et al.
Publicado: (2020)

A4 Development of HIV drug resistance in HIV-infected patients failing second line regimen in Zimbabwe: A public health concern
por: Kouamou, V, et al.
Publicado: (2018)

Incidence of Kaposi Sarcoma in HIV-infected patients – a prospective multi-cohort study from Southern Africa
por: Bohlius, Julia, et al.
Publicado: (2012)

Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS
por: Renner, Lorna A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vgr9gq741qjsjjihqo9uvq5gt6